Literature DB >> 34776692

Comparative Evaluation of Reconstructive Methods in Oral Submucous Fibrosis.

B C Sikkerimath1, Satyajit Dandagi1, Aditya Anshu1, Anu Jose1.   

Abstract

BACKGROUND: Oral submucous fibrosis is a chronic, progressive, scarring, precancerous condition of oral mucosa which on progression causes severe trismus. AIM AND
OBJECTIVES: To compare and evaluate the efficiency of buccal fat pad, platysmal mucocutaneous flap, nasolabial flap, collagen membrane graft, split thickness skin graft and temporoparietal fascia in reconstruction of surgical defect created by excision of fibrous bands in oral submucous fibrosis.
RESULTS: After 6 months of follow-up, the interincisal mouth opening was 40.0 mm in case of buccal pad fat, 24.5 mm in temporoparietal fascia flap group, 33.8 in collagen membrane graft group, 34.5 mm in platysma flap group, 34.7 mm in nasolabial flap group, 29.3 mm in split thickness skin graft. ANOVA statistical analysis for postoperative interincisal distance at various time intervals and between pre-, intra- and postoperative interincisal distances were carried out which showed the results were significant at p value < 0.05 in all groups. No postoperative complications were noted in buccal fat pad group, split thickness skin graft group and collagen membrane group. However, platysmal group had flap necrosis and temporoparietal flap group patients had to undergo a second debulking procedure after one month.
CONCLUSION: From our study, we concluded buccal fat pad yields superior results with respect to postoperative mouth opening and related complications. © The Association of Oral and Maxillofacial Surgeons of India 2021.

Entities:  

Keywords:  Buccal fat pad graft; Collagen membrane graft; Oral submucous fibrosis; Platysma flap; Split thickness skin graft; Temporoparietal flap

Year:  2021        PMID: 34776692      PMCID: PMC8554938          DOI: 10.1007/s12663-020-01493-x

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  19 in total

1.  FORMATION OF VESICLES IN ORAL SUBMUCOUS FIBROSIS.

Authors:  J J PINDBORG; B SINGH
Journal:  Acta Pathol Microbiol Scand       Date:  1964

Review 2.  Surgical Interventions in Oral Submucous Fibrosis: A Systematic Analysis of the Literature.

Authors:  Venkatesh V Kamath
Journal:  J Maxillofac Oral Surg       Date:  2014-12-25

3.  The temporoparietal galea flap.

Authors:  Luc Cesteleyn
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2003-11       Impact factor: 2.802

Review 4.  Oral submucous fibrosis: case report and review of diagnosis and treatment.

Authors:  Shahid R Aziz
Journal:  J Oral Maxillofac Surg       Date:  2008-11       Impact factor: 1.895

5.  Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases.

Authors:  J N Khanna; N N Andrade
Journal:  Int J Oral Maxillofac Surg       Date:  1995-12       Impact factor: 2.789

6.  Application of the buccal fat pad to the surgical treatment of oral submucous fibrosis.

Authors:  C J Yeh
Journal:  Int J Oral Maxillofac Surg       Date:  1996-04       Impact factor: 2.789

7.  Evaluation of inter-incisor distance as an objective criterion of the severity of oral submucous fibrosis in Karachi, Pakistan.

Authors:  R Maher; R Sankaranarayanan; N W Johnson; K A Warnakulasuriya
Journal:  Eur J Cancer B Oral Oncol       Date:  1996-09

Review 8.  An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.

Authors:  Samiha Bari; Rashmi Metgud; Zankhana Vyas; Aniruddh Tak
Journal:  J Cancer Res Ther       Date:  2017 Jul-Sep       Impact factor: 1.805

9.  Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases.

Authors:  D R Lai; H R Chen; L M Lin; Y L Huang; C C Tsai
Journal:  J Oral Pathol Med       Date:  1995-10       Impact factor: 4.253

10.  The versatile use of temporoparietal fascial flap.

Authors:  Cenk Demirdover; Baris Sahin; Haluk Vayvada; Hasan Yucel Oztan
Journal:  Int J Med Sci       Date:  2011-06-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.